Intravitreal aflibercept for choroidal neovascularisation in angioid streaks – (Eye 30, 896 (June 2016))
Intravitreal aflibercept for choroidal neovascularisation in angioid streaks Eye 30, 896 (June 2016). doi:10.1038/eye.2016.34 Authors: S Vaz-Pereira, L Collaço, G De Salvo & P van Zeller
Comment on: ‘Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’ – (Eye 30, 896 (June 2016))
Comment on: ‘Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’ Eye 30, 896 (June 2016). doi:10.1038/eye.2016.31 Authors: D Călugăru & M Călugăru
Reply to ‘Comment on: Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’ – (Eye 30, 897 (June 2016))
Reply to ‘Comment on: Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab’ Eye 30, 897 (June 2016). doi:10.1038/eye.2016.32 Authors: L C Olmos, M S Sayed & R K Lee
Comment on: ‘Effectiveness of a smartphone application for testing near-visual acuity’ – (Eye 30, 898 (June 2016))
Comment on: ‘Effectiveness of a smartphone application for testing near-visual acuity’ Eye 30, 898 (June 2016). doi:10.1038/eye.2016.35 Author: M Rodríguez-Vallejo
Comment on: ‘Effectiveness of a smartphone application for testing near visual acuity’ – (Eye 30, 899 (June 2016))
Comment on: ‘Effectiveness of a smartphone application for testing near visual acuity’ Eye 30, 899 (June 2016). doi:10.1038/eye.2016.36 Authors: I T Hossain, H H Malik & M Franka